The Board of Pharmacy posted two current Board Member Opportunities:
Also in Oregon, the Prescription Drug Affordability Board (PDAB) posted its draft agenda for the April 15 meeting. Check the PDAB website for updates prior to the meeting. Register in advance.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy implemented a new Pharmacy Law Test effective April 1, as part of updates to pharmacy initial licensing and renewal requirements. The changes are being administered through the National Association of Boards of Pharmacy’s (NABP’s) Electronic Licensure Transfer Program.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Reminder: federal law requires all providers who order, refer or prescribe services or items for Medicaid members to be enrolled in that state's Medicaid program. This requirement applies to pharmacist administering drugs as allowed under state protocols and submitting their NPIs in the prescriber field. Please review the Medicaid Enrollment of Ordering, Referring and Prescribing (ORP) Providers and Collection of ORP Data bulletin (MB# 25-015) published on July 2, 2025, as background.
Also in South Carolina, NACDS met with the Department of Health and Human Services (SCDHHS) on March 11 and inquired about mass enrollment of pharmacists as Medicaid providers. The provider enrollment department has informed NACDS that, unfortunately, due to system limitations and CMS requirements, they are unable to offer a mass enrollment process to any provider type.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
The Department of Health (TDH) continues to closely monitor respiratory syncytial virus (RSV) activity across the state. Recent emergency department data indicates that RSV activity remains elevated but has begun decreasing in Tennessee. Due to continued RSV activity in the state, pediatric providers and hospitals may continue to administer RSV immunizations to eligible infants through April 30. RSV immunizations remain available for ordering through TennIIS for the Vaccines for Children (VFC) program.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Lt. Gov. Dan Patrick (R) announced the Senate’s Interim charges, and Speaker Dustin Burrows laid out the House’s interim charges to prepare for the 2027 session.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Gov. Abigail Spanberger (D) signed SB 669 (Chapter 36)/HB 830, a key initiative of her administration to address PBM structure in the commercial market. The law will require all health insurance carriers to use a pass-through pricing model. It also will prohibit a PBM from reversing and/or resubmitting a pharmacy claim without meeting certain requirements; reducing any pharmacy payment through effective rates; and retroactively denying or reducing a claim or aggregate of claims, except under certain circumstances. Additionally, it requires the State Corporation Commission to compile a report of its examination of PBM steering practices with recommendations to the General Assembly by December 1, 2027.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Board of Pharmacy has released updated self-inspection worksheets for 2025, covering various pharmacy practice settings and specialties. The comprehensive collection includes worksheets for general pharmacy operations, hospitals and HPACs, manufacturers, wholesalers and healthcare entities. Additional specialized addenda are available for long-term care facilities and various USP standards including nonsterile compounding (USP 795), sterile compounding (USP 797), hazardous drugs (USP 800) and radiopharmaceuticals (USP 825).
The Board also published a 2025 DSCSA self-inspection worksheet to help pharmacies comply with Drug Supply Chain Security Act (DSCSA) requirements.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Gov. Patrick Morrisey (R) signed HB 5430 , a bill that will further strengthen the state’s oversight of PBMs in both the commercial market and under the Public Employees Insurance Agency (PEIA). The law eliminates spread pricing; prohibits PBMs from using offshore group purchasing organizations (GPOs) to divert drug rebates; requires a 2026 pharmacy cost of dispensing study; and gives the Insurance Commissioner additional tools to regulate and oversee PEIA’s PBM.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Department of Insurance (DOI) PBM Compliance Division has taken its first action against non-compliant PBMs. Actions have been filed against two entities: one taken in October against Drexi, Inc. for operating without a PBM license in the state, and one taken against Express Scripts, Inc. (ESI) this week for several violations, including charging of illegal fees; under payment of reimbursements; and failure and refusal to provide accounts, documents, records, files, information and matters relevant to the substance of complaints. The Department is enforcing Act 2025-36, also known as the Community Pharmacy Relief Act. Stay informed by visiting the DOI PBM Compliance Division page and the PBM Actions page.
Also in Alabama, the Board of Pharmacy proposed these rules for adoption. The required public comment period is now open, and we encourage all members to review them.
File written comments directly with the Board of Pharmacy as directed in the cover sheet for the rule. Deadlines for comments are provided on the rule filings. All written comments should be sent to Wpassmore@albop.com by the deadlines noted.
Finally in Alabama, the Board of Pharmacy scheduled several upcoming meetings for 2026, including April 15, May 20, June 17, July 15, August 19, September 16, October 14, November 18 and December 16. All meetings begin at 9:00 am CST/CDT unless otherwise noted.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
